ACRS
NASDAQStockAclaris Therapeutics, Inc.
$3.50-0.01 (-0.28%)
52-Week Range
$1.08
$4.53
Key Stats
Market Cap
422.1M
P/E Ratio
—
Dividend Yield
—
Beta
0.87
Volume
721.5K
Avg Volume
3.2M
Performance
1M
+10.03%
3M
+10.73%
6M
+90.76%
YTD
+21.87%
1Y
+122.15%
3Y
-56.77%
5Y
-85.23%
Price Chart
ETF Exposure
ACRS is held by 49 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| QQQS | Invesco NASDAQ Future Gen 200 ETF | 0.61% |
| SBIO | ALPS Medical Breakthroughs ETF | 0.25% |
| IWC | iShares Micro-Cap ETF | 0.07% |
| XS5E.SG | Xtrackers S&P 500 Swap UCITS ETF | 0.03% |
| XSXD.SG | Xtrackers S&P 500 Swap UCITS ETF | 0.03% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.03% |
| IBB | iShares Biotechnology ETF | 0.03% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.03% |
| IWN | iShares Russell 2000 Value ETF | 0.02% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.02% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.02% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.02% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.02% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.01% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| DXUV | Dimensional - US Vector Equity ETF | 0.00% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| DFAS | Dimensional - US Small Cap ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.00% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
About ACRS ETF Exposure
Aclaris Therapeutics, Inc. (ACRS) is held by 49 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 422.1M, ACRS is a widely held institutional stock. The stock currently trades at $3.50. Investors can gain exposure to ACRS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ACRS, sorted by portfolio weight.